Po, Alain Li Wan - In: PharmacoEconomics 14 (1998) 4, pp. 349-355
Companies merge to achieve economies of scale. In an industry such as the pharmaceutical industry which relies on a high level of investment in research and development, such mergers appear rational. However, it is not at all obvious that a higher level of investment by a smaller number of firms...